PAYMENT REVIEW OF

CORNING PHARMACEUTICAL SERVICES (ASIA)

18 JANUARY 2026

CORNING PHARMACEUTICAL SERVICES (ASIA) (ABN: 52816778B) is a business entity in Singapore registered with The Accounting and Corporate Regulatory Authority (ACRA) and is currently not operational. It has a payment reputation rating of 'D' under our scoring framework, and all transactions are recorded in Singapore Dollars (SGD).
Good: 29

Registrar Details

Entity Name
CORNING PHARMACEUTICAL SERVICES (ASIA)
UEN
52816778B
Entity Status
Terminated
Constitution
Sole-Proprietor
Entity Type
Sole Proprietorship/ Partnership
Primary Activity (SSIC)
72109
Research and experimental development on natural sciences n.e.c.
Secondary Activity (SSIC)
21022
Manufacture of other biological products and preparations for human use
Issuance Agency
ACRA
Registration Incorporation Date
05 March 1996
UEN Issue Date
05 March 1996
Registered Address
10 SCIENCE PARK ROAD THE ALPHA #03-12 SINGAPORE 117684
Number of Officers
2
Financial Reporting
Account Due Date
Data unavailable
Annual Return Date
Data unavailable
Audit Firms
Data unavailable
Former Names
Data unavailable

User Reviews
0

Loading reviews...

Review Anonymously

Help others understand CORNING PHARMACEUTICAL SERVICES (ASIA)'s payment practices.
D
Payment Rating

Going Concern

FAILED

Legal Name

CORNING PHARMACEUTICAL SERVICES (ASIA)

Registration Number

52816778B

Country Jurisdiction

SINGAPORE

Registered Date

05 MARCH 1996 (30 years 2 months ago)

Base Currency

SINGAPORE DOLLARS

Last Updated

18 JANUARY 2026 10:57 PM

Legal Invoice Recovery
Make a claim on CORNING PHARMACEUTICAL SERVICES (ASIA)

Frequently Asked Questions

The Payment Rating of CORNING PHARMACEUTICAL SERVICES (ASIA) is D. It is a proprietary metric aggregating verified public sources (court judgements, news media, financial analysis), community feedback and data partnerships. It indicates the likelihood of on-time payments but is not a financial guarantee.

CORNING PHARMACEUTICAL SERVICES (ASIA) has not passed the "Going Concern" test. This suggest that CORNING PHARMACEUTICAL SERVICES (ASIA) is operationally active and is likely to be able to meet financial obligations. More specifically, it means CORNING PHARMACEUTICAL SERVICES (ASIA) does not have significant reported poor payment reviews that is cause for distress and it is also not in the process of being liquidated, winding up, or struck off from the government registry.

Based on the registration date of 05 MARCH 1996 12:00 AM, CORNING PHARMACEUTICAL SERVICES (ASIA) is approximately 30 years old.

The business registration number of CORNING PHARMACEUTICAL SERVICES (ASIA) is 52816778B. The business registration number is a standard identification number assigned by government registrar to uniquely identify a business entity.

CORNING PHARMACEUTICAL SERVICES (ASIA) is officially located at 10 SCIENCE PARK ROAD THE ALPHA #03-12 SINGAPORE 117684. This is the registered address on file with the registrar.

CORNING PHARMACEUTICAL SERVICES (ASIA)'s primary industry is Research and experimental development on natural sciences n.e.c. (SSIC code: 72109) and secondary industry is Manufacture of other biological products and preparations for human use (SSIC code: 21022).

No. We are an open business directory and review platform. We do not issue credit ratings like Experian, Equifax, or Moody's. Our data, including Payment Ratings, should be used for reference only, not as the sole basis for financial decisions.

Business profile information is provided by official government registries, such as ACRA in Singapore, Australian Business Register, New Zealand Companies Register, and Companies House in the United Kingdom. Payment ratings and reviews are sourced from court notices or judgements, news media, financial analysis, data partnerships and user reported reviews.

Yes. Your identity is protected—reviews are published under the display name 'Anonymous' so businesses cannot identify who wrote them.​ While we verify that reviewers have a legitimate connection to the business (such as being a real supplier or customer), this verification happens privately and is never shared publicly. This approach mirrors how Glassdoor (and Reddit) protects reviewers from retaliation while ensuring reviews come from real people. Avoid including identifying details in your review text (like specific invoice numbers, unique transaction dates, or your company name) that could make you recognizable.

As an open platform, Payre democratizes payment risk information that would otherwise be expensive or difficult to access through traditional credit bureaus. You can share and read actual creditor experiences about late or non-payments to promote a prompt payment culture, influence debtor's management practice and help others make better decisions. We promise reviews to remain freely accessible to anyone.